Description: Stallergenes Greer is a global healthcare company specializing in the diagnosis and treatment of allergies through the allergy immunotherapy (AIT) products and services.
Landmark EfficAPSI study confirms significant benefit of sublingual liquid AIT treatment on the onset and worsening of asthma in patients with allergic rhinitis
Leading the way in the veterinary allergy space
Headquartered in Baar (Switzerland), Stallergenes Greer is a fully integrated global biopharmaceutical company specialising in the diagnosis and treatment of allergies.